Why is Welcure Drugs falling/rising?

As of 16-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 0.77, reflecting a change of 0.04 or 5.23% upward. The stock has shown a strong performance today, outperforming its sector by 5.22%. Additionally, the delivery volume on 15 October reached 69.84 lacs, which is a significant increase of 257.43% compared to the 5-day average delivery volume. However, it is important to note that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has risen by 17.04%, while its year-to-date performance shows a decline of 26.69%.
In the broader market context, the Sensex has increased by 1.58% over the past week, indicating that Welcure Drugs has significantly outperformed this benchmark during the same period. While the stock has shown positive short-term returns, its year-to-date performance remains negative compared to the Sensex, which has gained 6.82% year-to-date. The lack of specific positive or negative factors in the dashboard does not provide additional insights into the underlying reasons for the stock's recent movements, but the rising investor participation and liquidity suggest a growing interest in the stock despite its longer-term challenges.